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Abstract
Juvenile xanthogranuloma (JXG) is the most common non-Langerhans cell histiocytic disorder in
children. This report describes the case of a 28-day-old boy that presented with multiple sub-
cutaneous nodular lesions on the trunk and extremities, and multiple red nodular lesions on the
scrotum. Magnetic resonance imaging (MRI) of the brain showed a well-demarcated extra-axial
dura-based mass that appeared isointense or slightly hyperintense on T1-weighted images, hypo-
intense on T2-weighted images and had intense enhancement on gadolinium-enhanced T1-
weighted images. Computed tomography (CT) or MRI scans of the chest and abdomen revealed
multiple scattered nodular or patchy lesions of varying sizes in the lungs, liver and left kidney.
Histological analysis of a subcutaneous mass suggested JXG. The patient was diagnosed with
neonatal systemic JXG with involvement of the central nervous system, lungs, liver, kidneys,
subcutaneous soft tissue and skin. CT and MRI after 3 months of treatment with methylprednis-
olone sodium succinate demonstrated that the lesions were obviously diminished. This report
discusses the imaging findings in this current case of multi-organ JXG and reviews the imaging
literature on this condition to improve awareness of the lesions in order to help radiologists
establish an accurate differential diagnosis when confronted with similar cases.
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Introduction
Juvenile xanthogranuloma (JXG, also
called nevoxanthoendothelioma) is the
most common non-Langerhans cell histio-
cytic disorder in children.1 JXG, which is
caused by the proliferation or activation
of interstitial/dermal dendritic cells and
macrophages, occurs predominantly in
infancy and early childhood.2 JXG mainly
affects the skin and patients typically pre-
sent with multiple cutaneous papules or
nodules.3 However, between 3.9% and
5.0% of patients have lesions in extracuta-
neous organs, including the liver, spleen,
lungs, kidneys, eyes, subcutaneous soft
tissue, bones and central nervous system
(CNS).2,4,5 Clinically, JXG is divided into
cutaneous JXG, which only affects the
skin, and systemic JXG, which can affect
multiple extracutaneous organs with or
without skin lesions.4 Cutaneous JXG fol-
lows a benign course without treatment.6 In
contrast, systemic JXG can be associated
with complications that necessitate aggres-
sive medical care and imaging to monitor
extracutaneous lesions.5 A revised classifi-
cation system recently proposed to include
Langerhans cell histiocytosis (LCH),
Erdheim-Chester disease (ECD) and extrac-
utaneous JXG in the Langerhans group and
to consider as ECD all extracutaneous or
disseminated JXG with a gain-of-function
mutation of the BRAF, NRAS, KRAS or
MAP2K1 (grade D2) genes.7 It has also
been reported that more than half of
patients with ECD and LCH have
BRAFV600E mutations; and mutations
affecting the mitogen-activated protein
kinase pathway and phosphatidylinositol
3-kinase/protein kinase B pathway are pre-
sent in a large proportion of patients with
wild-type BRAF mutation.8 Mitogen-
activated protein kinase kinase enzyme
(MEK) inhibitors and combined anti-
BRAF and anti-MEK therapies also
appear promising.8
This current report describes a case of
neonatal systemic JXG with involvement
of the CNS, lungs, liver, kidneys, subcuta-
neous soft tissue and skin. This report also
reviews the imaging literature on this con-
dition and discusses the imaging findings of
JXG with multiple organ involvement to
improve awareness of the lesions. This
report may help radiologists establish an
accurate differential diagnosis when con-
fronted with similar cases.
Case report
A 28-day-old boy presented to the
Department of Radiology, Hunan
Children0s Hospital, Changsha, Hunan
Province, China in August 2018 with mul-
tiple subcutaneous nodular lesions on the
trunk and extremities, and multiple red
nodular lesions on the scrotum. The subcu-
taneous lesions were firm, the boundaries
were clear, and there were no adhesions
to the surrounding tissue. The largest
lesion, located on the right chest wall, mea-
sured approximately 2.5 2.0 1.5 cm
(Figure 1). On examination, the boy had
no focal neurological deficits or evidence
2 Journal of International Medical Research
of hepatosplenomegaly or superficial lymph
adenopathy. Laboratory results on admis-
sion showed: haemoglobin 93.0 g/l; total
protein 39.1 g/l; albumin 25.8 g/l; globulin
13.3 g/l; alpha-1-fetoprotein 2679.8 ng/ml.
To define the extent of the disease, brain
and abdominal magnetic resonance imaging
(MRI) and chest and abdominal computed
tomography (CT) were performed.
The MRI of the brain showed a well-
demarcated extra-axial dura-based lesion
with mass effect on the right temporal
lobe, measuring approximately 1.8 1.3
1.7 cm. The mass appeared isointense or
slightly hyperintense on T1-weighted
images (Figure 2A). The lateral portion of
the mass was slightly hypointense, and the
medial portion of the mass was hypointense
on T2-weighted images (Figure 2B) and
showed slightly restricted diffusion on
diffusion-weighted images (DWI) (Figures
2C and 2D). The mass was intense and
homogenously enhanced and demonstrated
a dural tail sign after intravenous gadolini-
um administration (Figure 2E).
A CT scan of the chest revealed multiple
bilateral peripheral pulmonary nodules of
varying sizes. The largest nodule, located
on the posterior aspect of the lower lobe
of the left lung, measured approximately
0.8 0.9 0.7 cm (Figures 3A and 3B).
A sharply circumscribed subcutaneous
mass in the right chest wall was present,
appearing as a homogeneous, solid
soft-tissue mass without calcification and
isoattenuating compared with muscle, mea-
suring approximately 1.1 2.1 1.7 cm. A
contrast-enhanced CT scan of the abdomen
revealed multiple scattered nodular or
patchy hypodense lesions of varying sizes
in the liver and left kidney and partial
lesions distributed along the portal vein
(Figures 3C–3H).
In MRI of the liver, T1-weighted images
showed lesions with signal intensity similar
to or less than that of the surrounding liver
parenchyma (Figure 4A) and T2-weighted
images showed lesions with slightly high
intensity (Figure 4B). In DWI, the nodule
located on the right liver subcapsular region
showed slightly restricted diffusion, and
curvilinear high intensity was present
along the periportal vein, and in an appar-
ent diffusion coefficient map, they appeared
hypointense (Figures 4C and 4D). The
largest kidney lesion had ill-defined
margins and measured approximately
1.2 1.3 0.9 cm. In MRI of the kidney,
T1-weighted images showed lesions with
signal intensity slightly higher than that of
the surrounding renal parenchyma and T2-
weighted images showed lesions with slight-
ly low intensity (Figure 4E). In DWI, the
lesions appeared hyperintense, and in an
apparent diffusion coefficient map, they
appeared hypointense (Figures 4F and 4G).
Histological analysis of biopsies of the
subcutaneous lesions located on the right
lower leg and forearm revealed a large
amount of monocytoid histiocytes, inflam-
matory cell infiltrates and Touton giant
cells (Figure 5A). Immunohistochemical
staining revealed that the lesion was strong-
ly positive for CD163 (Figure 5B) and
vimentin and negative for Ki-67, CD1a,
Figure 1. A subcutaneous nodular lesion located
on the right chest wall (arrow) of a 28-day-old boy
that presented with multiple subcutaneous nodular
lesions on the trunk and extremities, and multiple
red nodular lesions on the scrotum.
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S100 and Langerin. Together, the histology
and immunohistochemical profile of this
lesion was consistent with JXG. Whole
exome sequencing and phospho-
extracellular signal-related kinase staining
were not performed.
The patient was treated with 12mg
methylprednisolone sodium succinate
by intravenous drip once a day for 3 days
and 12mg methylprednisolone tablets
orally once a day for 12 weeks. After
3 months, MRI and CT re-examinations
revealed that the lesions were significantly
smaller than at the initial examination
(Figure 2F, 3I, 4H and 4I). This study
was approved by the Institutional
Review Board Committee at Hunan
Children’s Hospital (no. HCHLL-2020-
13). The parents of the patient participat-
ing in the study provided written informed
consent for this case report to be
published.
Figure 2. Brain magnetic resonance imaging scans of a 28-day-old boy that presented with multiple sub-
cutaneous nodular lesions on the trunk and extremities, and multiple red nodular lesions on the scrotum.
(A) An axial T1-weighted image shows an extra-axial dura-based isointense lesion (arrow) with mass effect
on the right temporal lobe. (B) An axial T2-weighted image shows that the lateral portion of the mass was
slightly hypointense and the medial portion of the mass was hypointense (arrow). (C and D) Diffusion-
weighted images show that the lateral portion of the mass had slightly restricted diffusion (arrows). (E) AT1-
weighted post-contrast axial image shows that the mass had intense homogenous enhancement (arrow) and
demonstrated a dural tail sign (short arrow). (F) After 3 months of treatment, the lesion was significantly
smaller.
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Discussion
The imaging findings from this current case
were similar to reports in the literature in
many ways but differed in a few aspects
that might be helpful to radiologists when
differentially diagnosing JXG. This discus-
sion will focus on a few of those key simi-
larities and differences.
In published reports,9,10 the appearance
of intracranial JXG lesions on MRI
varies. Lesions are usually round and are
hypointense, isointense or slightly hyperin-
tense on T1-weighted or T2-weighted
images. Lesions appear with or without
surrounding oedema, show restricted diffu-
sion on DWI, and can have either homog-
enous or heterogeneous enhancement on
gadolinium-enhanced T1-weighted images.
A previous report suggested that JXG diag-
nosis could be suggested by the presence of
a soft-tissue mass with high signal intensity
on T1-weighted images, lower signal inten-
sity on T2-weighted images than in the cere-
bral cortex, homogeneous enhancement
and decreased diffusivity.9 The current
case was consistent with this description.
The isointensity or slight hyperintensity in
T1-weighted images in lesions compared
Figure 3. Lung, liver and kidney computed tomography (CT) images of a 28-day-old boy that presented
with multiple subcutaneous nodular lesions on the trunk and extremities, and multiple red nodular lesions
on the scrotum. (A and B) Axial CT images of the chest (lung window) demonstrate multiple bilateral
peripheral pulmonary nodules of varying sizes (arrows). (C, D and E) Axial contrast-enhanced abdominal CT
images (arterial phase) demonstrate multiple scattered nodules or patchy hypodense lesions (arrows) in the
liver and left kidney that were mildly enhanced. Partial hepatic lesions were distributed along the portal vein
(short arrow). (F, G and H) Axial contrast-enhanced abdominal CT images (venous phase) demonstrate
multiple scattered nodules or patchy hypodense lesions in the liver and left kidney. (I) After 3 months of
treatment, the lesions in the lung were significantly smaller.
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with the cortex is presumably attributable
to the presence of lipid within the lesions.
Additionally, the hypointensity on T2-
weighted images and decreased diffusivity
may be attributable to reduced cellularity
or collagenous matrix.9 This issue cannot
be addressed in the current case because
the intracranial lesion was not analysed
histologically.
Several papers have reported JXG
lesions in the lungs.2,3,11–13 Patients with
pulmonary lesions commonly have systemic
disease and a worse prognosis than patients
without pulmonary lesions.11 On chest CT,
JXG lesions in the lung usually appear as
bilateral, diffuse micro- or macronod-
ules.3,12,13 Consistent with this description,
chest CT in the current case revealed mul-
tiple bilateral peripheral pulmonary nod-
ules of varying sizes. However, a previous
report noted that JXG lesions in the lung
can have an interstitial pattern with accom-
panying micronodules and mediastinal and
hilar lymphadenopathy and suggested that
Figure 4. Liver and kidney magnetic resonance imaging scans of a 28-day-old boy that presented with
multiple subcutaneous nodular lesions on the trunk and extremities, and multiple red nodular lesions on the
scrotum. (A) An axial T1-weighted image shows lesions with signal intensity similar to or less than that of the
surrounding liver parenchyma (arrows). (B) An axial T2-weighted image shows lesions with slightly high
intensity (arrows). (C and D) Diffusion-weighted images show curvilinear high intensity along the periportal
vein (arrow) and hypointensity in an apparent diffusion coefficient map. (E) An axial T2-weighted image
shows lesions with slightly low intensity than that of the surrounding renal parenchyma (arrow). (F and G)
Diffusion-weighted images reveal high signal and an apparent diffusion contrast map reveals a low signal,
confirming diffusion restriction in the lesions (arrow). (H and I) After 3 months of treatment, the lesions in
the liver and kidney were significantly smaller.
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such imaging findings should prompt radi-
ologists to consider JXG in the differential
diagnosis.3
Previous reports have described JXG
lesions in the kidney as isodense masses
that appeared hypodense in contrast-
enhanced CT.3,13 Consistent with this, scat-
tered nodular or patchy hypodense lesions of
varying sizes were observed in the left kidney
in the current case on contrast-enhanced CT.
In MRI, T2-weighted images showed lesions
with slightly low intensity and T1-weighted
images showed lesions with signal intensity
slightly higher than that of the surrounding
renal parenchyma. Lesions were hyperin-
tense on DWI and hypointense in an appar-
ent diffusion coefficient map, which may be
related to the accumulation of cells derived
from the monocyte and macrophage line-
ages, infiltration of inflammatory cells,
increased cell density and viscosity, resulting
in the restricted diffusion of water molecules.
To the best of our knowledge, this is the first
report of such features of renal JXG lesions.
Although such findings are likely not char-
acteristic, they may provide some clues for
diagnosis.
In the liver, JXG lesions have been
described as masses of soft-tissue attenua-
tion with minimal enhancement on CT.14
Additionally, MRI shows slightly high
signal intensity on T2-weighted images
and either slightly high or low signal inten-
sity on T1-weighted images.3,13,15 A previ-
ous report noted that on the venous phase,
a liver lesion was hypovascular and had a
central area of low attenuation, and the
hepatic lesions did not lose signal intensity
on opposed-phase compared with in-phase
gradient-echo images.15 Partial lesions dis-
tributed along the portal vein that were
slightly hyperintense on T2-weighted
images and slightly hypointense on
T1-weighted images were observed in
the current case. This current finding
may be similar to a JXG autopsy finding
in which histiocytes in the portal
tract spilled over into the adjacent
lobule.16 In DWI in the current case, the
nodule located on the right liver subcapsu-
lar region showed slightly restricted diffu-
sion and curvilinear high intensity
was present along the periportal vein. To
the best of our knowledge, the MRI
Figure 5. Histological analysis of biopsies of the subcutaneous lesions located on the right lower leg and
forearm of a 28-day-old boy revealed a large amount of monocytoid histiocytes, inflammatory cell infiltrates
and Touton giant cells. (A) Haematoxylin and eosin staining shows multi-regional histology and Touton giant
cells (arrow). (B) Immunohistochemical staining demonstrated that the legion was strongly positive for
CD163 (shown in the image) and vimentin and negative for S100 and Langerin. Scale bar 50 mm. The colour
version of this figure is available at: http://imr.sagepub.com.
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appearance of lesions in the liver has not
been described previously.
The diagnosis of JXG relies on clinical
and histopathological examinations. From
an imaging standpoint, the major differential
diagnoses for this current case were LCH,
infectious disease, multiple organ metastases
from a malignant tumour and tuberous scle-
rosis complex. Intracranial involvement in
LCH and JXG may have a similar appear-
ance, but liver involvement in LCH usually
shows hepatic parenchymal cyst-like lesions,
alternative stenoses and dilatation of the
intrahepatic ducts.17 Additionally, in LCH,
early imaging findings of lung involvement
include multiple nonspecific pulmonary nod-
ules, which cavitate into cysts over time.18
Infectious lesions may be ruled out by the
imaging findings of intracranial lesions and
laboratory results. To diagnose multi-organ
metastasis from a malignant tumour, the pri-
mary tumour can be found. In neonatal neu-
roblastoma, the primary tumour site is most
commonly in the adrenal gland. In neonatal
tuberous sclerosis complex, intracranial
involvement often manifests as subventricu-
lar and subcortical multiple nodules, and the
most common liver and renal anomalies are
the presence of angiomyolipomas.
In conclusion, JXG can involve multiple
extracutaneous organs and has a variety of
imaging manifestations. This current report
presents the imaging features of JXG with
involvement of the CNS, lungs, liver,
kidney and subcutaneous soft tissue.
Familiarity with the common locations
and imaging appearances may prompt radi-
ologists to establish a more accurate differ-
ential diagnosis for JXG. However, a
limitation of this case report was that
there was no genomic profiling to generate
options for targeted therapies.
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